Teva Pharmaceuticals

  • Cancer Jun 13, 2019

    Teva Pharmaceuticals Widens Recall on Blood Pressure Medication

    Teva Pharmaceuticals has expanded its recall of blood pressure and heart medicine by discontinuing sales of certain 50 mg and 100 mg strength losartan potassium USP Tablets, according to the U.S. Food and Drug Administration. Teva’s recall started on April 25 due to the detection of a carcinogen in an active ingredient. The drugs listed in recall notices this week...

  • United States May 11, 2019

    More Than 40 States Bring Price Fixing Suit Against Generic Drug Makers

    Attorneys general from more than 40 states are alleging the nation’s largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions.

  • New Jersey Aug 17, 2018

    EpiPen Shortage Has Parents Struggling During Back-to-School Season

    Brenda Thiel and Alyssa Wachtler live on opposite sides of the country. But they’ve got at least one thing in common: both have sons with severe nut allergies. And when they made their usual back-to-school trips to the pharmacy to procure their EpiPens for the new year, they were told the same thing. “The pharmacist literally walked up to me...

  • San Diego Dec 6, 2017

    Viagra Goes Generic: Pfizer to Launch Own Little White Pill

    The little blue pill that’s helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first generic competition next week. Pfizer Inc. will begin selling the white pill at half the $65-a-pill retail price on Monday, when its...

  • CEO Dec 16, 2016

    Mylan to Offer Generic EpiPen for $300 Next Week

    Mylan is about to start selling a generic version of its EpiPen injector for $300 per two-pack, under half the cost of the name-brand lifesaving drug, the pharmaceutical company announced Friday. The move comes after 20 state attorneys general launched a federal lawsuit alleging that Mylan and five other generic drug-makers artificially inflated and manipulated prices to reduce competition for...

Contact Us